Metabolic-Fit / 100
FORM by GBY review
Clear, all-inclusive compounded pricing for both molecules plus a real FDA-approved Wegovy path — but that brand-name option is sold as a membership with the drug's own cost not clearly itemized, and state coverage is only documented for a handful of states.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
FORM by GBY at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- CA, MA, VT confirmed (RI pending); other states not disclosed
- Brand-name
- Yes
How we scored FORM by GBY
Each factor is scored from FORM by GBY's real pricing, disclosures and oversight, then combined into the 51/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.formbygby.com/semaglutide
Verified directly against formbygby.com 2026-08-04 (owner-named candidate, parent brand GBY Beauty). Compounded semaglutide $299/mo and tirzepatide $399/mo both stated all-inclusive. A separate Wegovy® membership is $95/mo, but the medication's own cost is not clearly itemized as included — flagged in pricing notes/cons rather than headlined, matching the network's PlushCare-pattern rule. State coverage is NOT company-wide-published; the only concrete figures come from a telehealth-consent document naming one clinician's individual state licenses (CA, MA, VT; RI pending). Distinct company from the existing 'form-health' (formhealth.co) roster entry — verified the domains, names, and parent-brand ownership do not overlap.
What to expect when you sign up
We walked FORM by GBY's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Parent brand is GBY Beauty; FORM is its provider-guided telehealth line covering GLP-1 weight loss, peptides, hair, and longevity
- 2Dedicated /semaglutide, /tirzepatide, /wegovy, and /zepbound pages each state a price and a 'compounded medications are not FDA approved' disclaimer where relevant
- 3A telehealth consent document names the clinical director's individual state licenses — California, Massachusetts, and Vermont, with Rhode Island listed as pending
What we noticed
- The compounded semaglutide ($299/mo) and tirzepatide ($399/mo) pages both describe all-inclusive pricing with no itemization gap
- The separate Wegovy® membership ($95/mo) is the one line here that reads like the PlushCare pattern this network watches for — a membership fee with the drug's own cost not clearly itemized inside it — so it is noted, not treated as the headline price
- State coverage is only documented for one named clinician (CA, MA, VT; RI pending) in a consent document, not published as a company-wide list — treat wider availability as unconfirmed
- No named compounding pharmacy found on the public site
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionSite states 'transparent, all-inclusive pricing' with intake/consultation costs outlined before you begin. |
| Compounded tirzepatide | $399 | InjectionSame all-inclusive structure as the semaglutide injection. |
| Brand semaglutide | $95 | Wegovy® membershipA $95/mo membership grants access to FDA-approved Wegovy; the site does not clearly itemize whether the medication's own cost is included in that fee or billed separately — treat the $95 as a membership fee only, not the all-in Wegovy price. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect FORM by GBY's public disclosures at last review and change often; confirm the current number on FORM by GBY's own site.
What we like
- Compounded semaglutide and tirzepatide are both clearly all-inclusive at $299/mo and $399/mo
- One of the few candidates verified this pass offering a path to FDA-approved brand-name Wegovy®, not compounded-only
- Dedicated, specific product pages for each drug rather than one generic weight-loss page
- Real parent-brand ownership (GBY Beauty) disclosed, not an anonymous shell
The caveats
- The $95/mo Wegovy membership does not clearly itemize whether the medication's own cost is included — confirm the all-in number before you sign up
- No company-wide state list published; the only concrete figures name just three states (CA, MA, VT) for one clinician
- No named compounding pharmacy disclosed
- Nothing on the site addresses pregnancy, breastfeeding, or postpartum timing
FORM by GBY for mothers: our verdict
Clear, all-inclusive compounded pricing for both molecules plus a real FDA-approved Wegovy path — but that brand-name option is sold as a membership with the drug's own cost not clearly itemized, and state coverage is only documented for a handful of states. It runs about $299/month, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh FORM by GBY the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What FORM by GBY actually costs
- Compounded semaglutide — Injection: $299/mo
- Compounded tirzepatide — Injection: $399/mo
- Brand-name semaglutide — Wegovy® membership: $95/mo
For context, the typical ongoing price across our roster is around $169/month, so FORM by GBY sits at the premium end.
The medications FORM by GBY prescribes
FORM by GBY prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where FORM by GBY fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
FORM by GBY is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want the option of an FDA-approved brand-name pen alongside compounded semaglutide/tirzepatide from one provider, and who will get the Wegovy membership's all-in cost confirmed in writing before signing up.
Alternatives to FORM by GBY
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing FORM by GBY
Head-to-head & alternatives
FORM by GBY, answered
- Is 'FORM by GBY' the same company as the 'Form Health' review on this site?
- No — they're unrelated. Form Health (formhealth.co) is a separate, previously-reviewed company. FORM by GBY (formbygby.com) is the telehealth line of GBY Beauty, a different business, verified independently for this review.
- What does FORM by GBY cost?
- Compounded semaglutide is $299/mo and compounded tirzepatide is $399/mo, both stated as all-inclusive. FORM also offers a separate $95/mo membership for access to FDA-approved Wegovy®, but the medication's own cost isn't clearly itemized inside that fee — get that number in writing before assuming $95 is the full price of brand-name Wegovy.
- Is FORM by GBY available in my state?
- FORM doesn't publish a company-wide state list. The only concrete figures we found were in a telehealth-consent document naming one clinician's individual licenses — California, Massachusetts, and Vermont, with Rhode Island pending. Don't assume broader availability without confirming directly.
Pricing, states and verification reflect FORM by GBY's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.